Evidence map›Paper›PMID 35539281›Full record

ArticleRSC advances2018

Sensitive quantitative analysis of the bitter glycoside amarogentin by specific monoclonal antibody-based indirect competitive enzyme-linked immunosorbent assay.

Seiichi Sakamoto, Shinji Wada, Hiroyuki Tanaka, Satoshi Morimoto

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Seiichi SakamotoDepartment of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University 3-1-1 Maidashi, Higashi-ku Fukuoka 812-8582 Japan s.sakamoto@phar.kyushu-u.ac.jp htanaka@phar.kyushu-u.ac.jp +81 92 642 6581 +81 92 642 6581.ORCID https://orcid.org/0000-0001-6871-522X
Shinji WadaDepartment of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University 3-1-1 Maidashi, Higashi-ku Fukuoka 812-8582 Japan s.sakamoto@phar.kyushu-u.ac.jp htanaka@phar.kyushu-u.ac.jp +81 92 642 6581 +81 92 642 6581.
Hiroyuki TanakaDepartment of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University 3-1-1 Maidashi, Higashi-ku Fukuoka 812-8582 Japan s.sakamoto@phar.kyushu-u.ac.jp htanaka@phar.kyushu-u.ac.jp +81 92 642 6581 +81 92 642 6581.
Satoshi MorimotoDepartment of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University 3-1-1 Maidashi, Higashi-ku Fukuoka 812-8582 Japan s.sakamoto@phar.kyushu-u.ac.jp htanaka@phar.kyushu-u.ac.jp +81 92 642 6581 +81 92 642 6581.
Kyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amarogentin (AG) is a naturally occurring secoiridoid glycoside produced mainly in the plant genera

Identifiers

PMID35539281
PMCPMC9080458
OpenAlexW2802009150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.